Evaluating the Effectiveness of Simvastatin in Slowing the Progression of Disability in Secondary Progressive Multiple Sclerosis (MS-STAT2): Protocol for a Multicentre, Randomised Controlled, Double-Blind, Phase 3 Clinical Trial in the UK Jeremy Chataway , Thomas Williams , James Blackstone , Floriana De Angelis , Alessia Bianchi , Alberto Calvi , Anisha Doshi , Nevin A. John , Sean Apap Mangion , Charles Wade , Rachel Merry , Gil Barton , Dawn Lyle , Elisabeth Jarman , Don Mahad , Abdullahi Shehu , Tarunya Arun , Gavin McDonnell , Ruth Geraldes , Matthew Craner , Charles Hillier , Jeban Ganesalingam , Leonora Fisniku , Jeremy Hobart , Cord Spilker , Neil Robertson , Seema Kalra , Stefano Pluchino , Sreedharan Harikrishnan , Miriam Mattoscio , Timothy Harrower , Carolyn Young , Martin Lee , Suresh Kumar Chhetri , Fayyaz Ahmed , David Rog , Eli Silber , Paul Gallagher , Martin Duddy , Agne Straukiene , Richard Nicholas , Claire Rice , Ekaterina Bordea , Rachael Hunter , Annie Hawton , Stuart Nixon , Judy Beveridge , Susan Tebbs , Marie Braisher , Gavin Giovannoni , Olga Ciccarelli , John Greenwood , Alan Thompson , Sue Pavitt , Owen Pearson , Nikos Evangelou , Basil Sharrack , Ian Galea , Siddharthan Chandran , Helen Ford , Jennifer Nicholas , Chris Frost MULTIPLE SCLEROSIS JOURNAL（2024）
关键词
Multiple sclerosis, Clinical Trial, Drug Therapy
AI 理解论文
溯源树
样例
